Difficult to believe that BOT is the only play progressing clinical trials for derma based CBD applications........"Only 1 trial in dermatology(Botanix)"
"Botanix holds the exclusive rights to utilise Permetrex for all drugs that treat skin diseases".........."Permetrex™ technology enables superior delivery of cannabidiol"........
Seriously looking forward to seeing these trial results........and very much awaiting some positive news re the possible functionality of the antimicrobial BTX1801....
Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-3
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 160000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11013 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
